| Literature DB >> 28435445 |
Sharon L Casapulla1,2,3,4, Cheryl A Howe5,3, Gabriela Rosero Mora6, Darlene Berryman5,3,7, Mario J Grijalva3,7,4, Edgar W Rojas8,9, Masato Nakazawa7, Jay H Shubrook3,10.
Abstract
BACKGROUND: Excess weight (overweight and obesity) is the major modifiable risk factor for type 2 diabetes mellitus (T2DM) and other non-communicable diseases. However, excess weight may not be as predictive of diabetes risk as once thought. While excess weight and other obesity-related non-communicable diseases are of growing concern in low-middle income countries in Latin America, there is limited research on risk factors associated with T2DM in adolescents. This study investigated prevalence of overweight, obesity, prediabetes, diabetes and metabolic syndrome in adolescents in Ecuador.Entities:
Year: 2017 PMID: 28435445 PMCID: PMC5397823 DOI: 10.1186/s13098-017-0224-2
Source DB: PubMed Journal: Diabetol Metab Syndr ISSN: 1758-5996 Impact factor: 3.320
Fig. 1Recruitment of participants, including drop outs at each stage and remaining number of participants
Frequency distributions by sex and location
| Total | Male | Female | ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| % | |
| Total sample | 433 | 138 | 31.9 | 295 | 68.1 | |
| Location | ||||||
| Cariamanga | 214 | 49.4 | 67 | 31.3 | 147 | 68.7 |
| Pomasqui | 219 | 50.6 | 71 | 32.4 | 148 | 67.6 |
Characteristics of sample overall and by location and sex
| Overall | Cariamanga sample | Pomasqui sample | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | Female | Male | All | Female | Male | ||||||||||||||||
| n | Mean | SD | n | Mean | SD | n | Mean | SD | n | Mean | SD | n | Mean | SD | n | Mean | SD | n | Mean | SD | |
| Age (years) | 433 | 15.1 | 1.6 | 214 | 14.8 | 1.5 | 147 | 14.8 | 1.5 | 67 | 14.8 | 1.5 | 219 | 15.4 | 1.6 | 148 | 15.4 | 1.7 | 71 | 15.4 | 1.7 |
| Height (cm) | 428 | 155.7 | 7.9 | 214 | 154.1 | 7.5 | 147 | 152.4 | 5.3 | 67 | 157.8 | 10.0 | 214 | 157.3 | 7.9 | 14 | 154.6 | 5.7 | 69 | 163.2 | 8.7 |
| Weight (kg) | 433 | 50.4 | 9.9 | 214 | 49.2 | 9.5 | 147 | 49.2 | 8.5 | 67 | 49.1 | 11.5 | 219 | 51.5 | 10.2 | 148 | 50.5 | 9.4 | 71 | 53.5 | 11.6 |
| Waist (cm) | 428 | 73.8 | 8.9 | 214 | 73.1 | 8.3 | 147 | 74.2 | 7.5 | 67 | 70.7 | 9.5 | 214 | 74.6 | 9.3 | 145 | 74.9 | 9.5 | 69 | 73.9 | 8.9 |
| Hip (cm) | 428 | 88.8 | 8.3 | 214 | 86.4 | 7.9 | 147 | 87.3 | 6.8 | 67 | 84.2 | 9.6 | 214 | 91.2 | 7.9 | 145 | 92.5 | 7.5 | 69 | 88.6 | 8.3 |
| WHR | 428 | 0.83 | 0.05 | 214 | 0.85 | 0.04 | 147 | 0.85 | 0.04 | 67 | 0.84 | 0.05 | 214 | 0.82 | 0.06 | 145 | 0.81 | 0.06 | 69 | 0.83 | 0.05 |
| BMI (kg/m2) | 428 | 20.7 | 3.4 | 214 | 20.6 | 3.2 | 147 | 21.2 | 3.2 | 67 | 19.5 | 3.0 | 214 | 20.7 | 3.6 | 145 | 21.1 | 3.7 | 69 | 19.9 | 3.3 |
| SBP (mmHg) | 428 | 103.3 | 10.8 | 214 | 104.4 | 10.6 | 147 | 103.4 | 10.4 | 67 | 106.6 | 10.6 | 214 | 102.1 | 10.9 | 145 | 100.9 | 9.7 | 69 | 104.7 | 12.7 |
| DBP (mmHg) | 428 | 69.0 | 8.5 | 214 | 71.0 | 8.1 | 147 | 70.3 | 7.7 | 67 | 72.7 | 8.8 | 218 | 67.2 | 8.5 | 147 | 66.8 | 8.2 | 71 | 68.1 | 9.2 |
| HR (bpm) | 428 | 76.3 | 14.4 | 214 | 77.8 | 17.6 | 147 | 77.8 | 17.4 | 67 | 77.8 | 18.1 | 214 | 74.8 | 10.0 | 145 | 77.0 | 9.8 | 69 | 70.2 | 9.0 |
| HbA1c (mg/dL) | 427 | 5.4 | 0.3 | 212 | 5.3 | 0.3 | 145 | 5.3 | 0.2 | 67 | 5.3 | 0.3 | 215 | 5.4 | 0.3 | 147 | 5.4 | 0.3 | 68 | 5.5 | 0.3 |
| FBG (mg/dL) | 375 | 81.9 | 9.5 | 161 | 79.4 | 10.4 | 114 | 79.2 | 9.1 | 67 | 80.1 | 13.2 | 214 | 83.8 | 8.4 | 145 | 83.0 | 8.5 | 69 | 85.4 | 7.7 |
| HDL (mg/dL) | 428 | 50.6 | 14.7 | 212 | 46.3 | 15.7 | 145 | 47.9 | 14.8 | 67 | 42.7 | 16.9 | 216 | 54.8 | 12.3 | 147 | 55.8 | 12.3 | 69 | 52.8 | 12.3 |
| TC (mg/dL) | 428 | 149.6 | 36.1 | 212 | 137.8 | 39.8 | 145 | 145.8 | 38.1 | 67 | 120.4 | 38.0 | 216 | 161.3 | 27.5 | 147 | 165.5 | 27.8 | 69 | 152.2 | 24.9 |
WHR wait-to-hip ratio; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; HbA1c glycated hemoglobin; TC total cholesterol; TG triglyceride; HDL high density lipoprotein; LDL low density lipoprotein; VLDL very low density lipoprotein; FBG fasting blood glucose
aData are represented as mean ± SD, except for TG, LDL, and VLDL who are represented as median [IQR] and (range)
Percent of sample with each weight class and HbA1c range overall and by location
| Overall | Cariamangaa | Pomasquia | Maleb | Femalea | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | |
| WHO weight classificationc | ||||||||||
| Underweight | 31 | 7.3 | 14 | 6.5 | 17 | 8.0 | 17 | 12.5 | 14 | 4.8 |
| Healthy weight | 328 | 76.8 | 162 | 75.7 | 166 | 77.9 | 105 | 77.2 | 223 | 76.6 |
| Overweight | 41 | 9.6 | 22 | 10.3 | 19 | 8.9 | 9 | 6.6 | 32 | 11.0 |
| Obese | 27 | 6.3 | 16 | 7.5 | 11 | 5.2 | 5 | 3.7 | 22 | 7.6 |
| IOTF weight classification | ||||||||||
| Thinness grade 3 | 15 | 3.5 | 8 | 3.7 | 7 | 3.3 | 8 | 5.9 | 7 | 2.4 |
| Thinness grade 2 | 37 | 8.7 | 17 | 7.9 | 20 | 9.4 | 19 | 14.0 | 18 | 6.2 |
| Thinness grade 1 | 69 | 16.2 | 33 | 15.4 | 36 | 16.9 | 27 | 19.9 | 42 | 14.4 |
| Healthy weight | 256 | 60.0 | 125 | 58.4 | 131 | 61.5 | 73 | 53.7 | 183 | 62.9 |
| Overweight | 42 | 9.8 | 29 | 13.6 | 13 | 6.1 | 6 | 4.4 | 36 | 12.4 |
| Obese | 8 | 1.9 | 2 | 0.9 | 6 | 2.8 | 3 | 2.2 | 5 | 1.7 |
| HbA1c status | ||||||||||
| HbA1c <5.7 | 374 | 87.6 | 200 | 174 | 115 | 259 | ||||
| HbA1c 5.7–6.4 | 53 | 12.4 | 12 | 41 | 20 | 33 | ||||
| HbA1c ≥6.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
aApplying Chi square test, there is no significant difference
bApplying Chi square test, there is significant difference P = 0.009 WHO Class and P = 0.002 IOTF Class
cClassification using percentiles
Regression analyses of the cardiometabolic risk factors, anthropometrics and hemodynamics
| (Intercept) | Sex (male) | Location (urban) | Sex x location | |
|---|---|---|---|---|
| HbA1c (units) | 5.28 ± 0.02*** | 0.04 ± 0.04 | 0.15 ± 0.03*** | −0.01 ± 0.05 |
| FBG (mg/dL) | 79.17 ± 0.87*** | 0.90 ± 1.61 | 3.85 ± 1.16** | 1.49 ± 2.10 |
| TG (mg/dL) | 82.17 ± 3.23*** | −13.11 ± 5.74* | 9.5 ± 4.55* | 5.66 ± 8.07 |
| TC (mg/dL) | 145.8 ± 2.73*** | −25.4 ± 4.86*** | 19.72 ± 3.85*** | 12.04 ± 6.84 |
| HDL (mg/dL) | 47.94 ± 1.16*** | −5.27 ± 2.06* | 7.82 ± 1.63*** | 2.26 ± 2.9 |
| VLDL (mg/dL) | 16.46 ± 0.65*** | −2.61 ± 1.15* | 1.85 ± 0.91* | 1.11 ± 1.62 |
| LDL (mg/dL) | 81.58 ± 2.09*** | −16.52 ± 3.72*** | 9.86 ± 2.95*** | 7.64 ± 5.23 |
| Waist (cm) | 74.22 ± 0.72*** | −3.49 ± 1.29** | 0.68 ± 1.03 | 2.47 ± 1.82 |
| Hip (cm) | 0.85 ± 0.0*** | −0.01 ± 0.01 | −0.04 ± 0.01*** | 0.03 ± 0.01*** |
| BMI (kg/m2) | 21.16 ± 0.28*** | −1.68 ± 0.49*** | −0.1 ± 0.39 | 0.51 ± 0.69 |
| SBP (mmHg) | 103.44 ± 0.88*** | 3.11 ± 1.57* | −2.59 ± 1.24* | 0.76 ± 2.2 |
| DBP (mmHg) | 70.26 ± 0.68*** | 2.42 ± 1.22* | −3.46 ± 0.97*** | −1.15 ± 1.71 |
Data are expressed as β ± standard error
WHR wait-to-hip ratio; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; HbA1c glycated hemoglobin; TC total cholesterol; TG triglyceride; HDL high density lipoprotein; LDL low density lipoprotein; VLDL very low density lipoprotein; FBG fasting blood glucose
* p < 0.05, ** p < 0.01, *** p < 0.001